Literature DB >> 33520799

Comparison of EWGSOP-1and EWGSOP-2 diagnostic criteria on prevalence of and risk factors for sarcopenia among Iranian older people: the Bushehr Elderly Health (BEH) program.

Gita Shafiee1, Ramin Heshmat1, Afshin Ostovar2, Fatemeh Khatami1, Noushin Fahimfar2, Seyed Masoud Arzaghi3, Safoora Gharibzadeh2, Sara Hanaei4,5, Iraj Nabipour6, Bagher Larijani7.   

Abstract

BACKGROUND: This study proposed to compare the prevalence and risk factors for sarcopenia by EGWSOP-1 and EWGSOP-2 diagnostic criteria in Iran.
METHODS: This cross-sectional study was conducted based on the data collected during the Bushehr Elderly Health (BEH) Program, stage II. Sarcopenia was defined as 3 definitions: EWGSOP-1(with Iranian cut off), EWGSOP-2(with Iranian cut off), EWGSOP-2(with European cut off) definition. We evaluated the age-standardized prevalence of sarcopenia in both genders. Regression analysis was used to show the associations in the adjusted models.
RESULTS: Among 2426 participants, age-standardized prevalence of sarcopenia, and severe sarcopenia by EWGSOP-1 were 19.7%, and 12.9%, in men and 13.6%, and 16.7% in women, respectively. When we used EWGSOP-2 (with Iranian cut-off) criteria, these values were 10.5%, and 12.7% among men and 7.13% and 16.5% in women, respectively. The prevalence sarcopenia and severe sarcopenia by EWGSOP-2 (with European cut-off) were 12.7%, and 13.4% in men and 5.42%, and 13.7% in women, respectively. In both genders, getting older and high-fat mass were positively associated with sarcopenia, and BMI had a significant inverse association in both genders and all defintions.
CONCLUSIONS: Results showed that a prevalence of sarcopenia varied largely by using different criteria, in both sexes. EWGSOP2- defined sarcopenia prevalence was lower than that defined using EWGSOP-1 criteria due to different diagnostic factors to detect sarcopenia. Some adverse outcomes should be considered for evaluating sarcopenia to compare the accuracy of EWGSOP-1 and EWGSOP-2. © Springer Nature Switzerland AG 2020.

Entities:  

Keywords:  EWGSOP-1; EWGSOP-2; Prevalence; Sarcopenia

Year:  2020        PMID: 33520799      PMCID: PMC7843815          DOI: 10.1007/s40200-020-00553-w

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN: 2251-6581


  31 in total

1.  Sarcopenia and its associated factors in Iranian older individuals: Results of SARIR study.

Authors:  Rezvan Hashemi; Gita Shafiee; Ahmadreza Dorosty Motlagh; Parvin Pasalar; Ahmad Esmailzadeh; Fereydoun Siassi; Bagher Larijani; Ramin Heshmat
Journal:  Arch Gerontol Geriatr       Date:  2016-04-28       Impact factor: 3.250

2.  Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study.

Authors:  Darryl P Leong; Koon K Teo; Sumathy Rangarajan; Patricio Lopez-Jaramillo; Alvaro Avezum; Andres Orlandini; Pamela Seron; Suad H Ahmed; Annika Rosengren; Roya Kelishadi; Omar Rahman; Sumathi Swaminathan; Romaina Iqbal; Rajeev Gupta; Scott A Lear; Aytekin Oguz; Khalid Yusoff; Katarzyna Zatonska; Jephat Chifamba; Ehimario Igumbor; Viswanathan Mohan; Ranjit Mohan Anjana; Hongqiu Gu; Wei Li; Salim Yusuf
Journal:  Lancet       Date:  2015-05-13       Impact factor: 79.321

3.  Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia.

Authors:  Liang-Kung Chen; Li-Kuo Liu; Jean Woo; Prasert Assantachai; Tung-Wai Auyeung; Kamaruzzaman Shahrul Bahyah; Ming-Yueh Chou; Liang-Yu Chen; Pi-Shan Hsu; Orapitchaya Krairit; Jenny S W Lee; Wei-Ju Lee; Yunhwan Lee; Chih-Kuang Liang; Panita Limpawattana; Chu-Sheng Lin; Li-Ning Peng; Shosuke Satake; Takao Suzuki; Chang Won Won; Chih-Hsing Wu; Si-Nan Wu; Teimei Zhang; Ping Zeng; Masahiro Akishita; Hidenori Arai
Journal:  J Am Med Dir Assoc       Date:  2014-02       Impact factor: 4.669

4.  Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People.

Authors:  Alfonso J Cruz-Jentoft; Jean Pierre Baeyens; Jürgen M Bauer; Yves Boirie; Tommy Cederholm; Francesco Landi; Finbarr C Martin; Jean-Pierre Michel; Yves Rolland; Stéphane M Schneider; Eva Topinková; Maurits Vandewoude; Mauro Zamboni
Journal:  Age Ageing       Date:  2010-04-13       Impact factor: 10.668

5.  Difference in sarcopenia prevalence and associated factors according to 2010 and 2018 European consensus (EWGSOP) in elderly patients with type 2 diabetes mellitus.

Authors:  Mauren M de Freitas; Vanessa L P de Oliveira; Thaiciane Grassi; Kamila Valduga; Maria Elisa P Miller; Renata A Schuchmann; Karen L A Souza; Mirela J de Azevedo; Luciana V Viana; Tatiana P de Paula
Journal:  Exp Gerontol       Date:  2020-01-15       Impact factor: 4.032

Review 6.  Dysmobility syndrome: current perspectives.

Authors:  Keith D Hill; Kaela Farrier; Melissa Russell; Elissa Burton
Journal:  Clin Interv Aging       Date:  2017-01-16       Impact factor: 4.458

Review 7.  Epidemiology of Sarcopenia: Determinants Throughout the Lifecourse.

Authors:  S C Shaw; E M Dennison; C Cooper
Journal:  Calcif Tissue Int       Date:  2017-04-18       Impact factor: 4.333

8.  Sarcopenia: revised European consensus on definition and diagnosis.

Authors:  Alfonso J Cruz-Jentoft; Gϋlistan Bahat; Jϋrgen Bauer; Yves Boirie; Olivier Bruyère; Tommy Cederholm; Cyrus Cooper; Francesco Landi; Yves Rolland; Avan Aihie Sayer; Stéphane M Schneider; Cornel C Sieber; Eva Topinkova; Maurits Vandewoude; Marjolein Visser; Mauro Zamboni
Journal:  Age Ageing       Date:  2019-07-01       Impact factor: 10.668

9.  Sarcopenia: revised European consensus on definition and diagnosis.

Authors:  Alfonso J Cruz-Jentoft; Gülistan Bahat; Jürgen Bauer; Yves Boirie; Olivier Bruyère; Tommy Cederholm; Cyrus Cooper; Francesco Landi; Yves Rolland; Avan Aihie Sayer; Stéphane M Schneider; Cornel C Sieber; Eva Topinkova; Maurits Vandewoude; Marjolein Visser; Mauro Zamboni
Journal:  Age Ageing       Date:  2019-01-01       Impact factor: 10.668

10.  Interrater reliability: the kappa statistic.

Authors:  Mary L McHugh
Journal:  Biochem Med (Zagreb)       Date:  2012       Impact factor: 2.313

View more
  13 in total

1.  Malnutrition, assessed by the Global Leadership Initiative on Malnutrition (GLIM) criteria but not by the mini nutritional assessment (MNA), predicts the incidence of sarcopenia over a 5-year in the SarcoPhAge cohort.

Authors:  Laetitia Lengelé; Olivier Bruyère; Charlotte Beaudart; Jean-Yves Reginster; Médéa Locquet
Journal:  Aging Clin Exp Res       Date:  2021-05-15       Impact factor: 3.636

Review 2.  Prevalence of sarcopenia according to EWGSOP1 and EWGSOP2 in older adults and their associations with unfavorable health outcomes: a systematic review.

Authors:  Erick P de Oliveira; Laura Cristina Jardim Porto; Lara Vilar Fernandes; Alexandre Elias Gomes Paiva; Ana Clara Borges Silva; Isabela Coelho de Castro; Andrezza Fernanda Santiago
Journal:  Aging Clin Exp Res       Date:  2021-08-16       Impact factor: 3.636

3.  The association between muscle indicators and bone mass density and related risk factors in the diabetic elderly population: Bushehr Elderly Health (BEH) Program.

Authors:  Marzieh Nikfarjam; Ramin Heshmat; Safoora Gharibzadeh; Afshin Ostovar; Vahid Maleki; Jalal Moludi; Iraj Nabipour; Gita Shafiee; Bagher Larijani
Journal:  J Diabetes Metab Disord       Date:  2021-08-25

4.  Sarcopenia and mortality risk in community-dwelling Brazilian older adults.

Authors:  Cristina Camargo Pereira; Valéria Pagotto; Cesar de Oliveira; Erika Aparecida Silveira
Journal:  Sci Rep       Date:  2022-10-20       Impact factor: 4.996

5.  European Working Group on Sarcopenia in Older People (EWGSOP2) Criteria With Population-Based Skeletal Muscle Index Best Predicts Mortality in Asians With Cirrhosis.

Authors:  Abhinav Anand; Srikant Mohta; Samagra Agarwal; Sanchit Sharma; Srikanth Gopi; Deepak Gunjan; Kumble S Madhusudhan; Namrata Singh; Anoop Saraya
Journal:  J Clin Exp Hepatol       Date:  2021-04-08

6.  Association between Healthy Eating Index-2015 scores and probable sarcopenia in community-dwelling Iranian older adults: a cross-sectional study.

Authors:  Zahra Esmaeily; Zahra Tajary; Sharzad Daei; Mahshid Rezaei; Atefeh Eyvazkhani; Ahmad Reza Dorosty Motlagh; Andriko Palmowski
Journal:  J Nutr Sci       Date:  2021-03-25

7.  Cut-off points to screening for sarcopenia in community-dwelling older people residents in Brazil.

Authors:  Sabrina Gabrielle Gomes Fernandes; Luiz Eduardo Lima de Andrade; Rafaella Silva Dos Santos Aguiar Gonçalves; Saionara Maria Aires da Câmara; Ricardo Oliveira Guerra; Alvaro Campos Cavalcanti Maciel
Journal:  PeerJ       Date:  2021-08-25       Impact factor: 2.984

8.  Identification of Sarcopenic Obesity in German Nursing Home Residents-The Role of Body Composition and Malnutrition in the BaSAlt Cohort-Study.

Authors:  Daniel Haigis; Leon Matting; Silas Wagner; Gorden Sudeck; Annika Frahsa; Ansgar Thiel; Gerhard Eschweiler; Andreas Michael Nieß
Journal:  Nutrients       Date:  2021-10-26       Impact factor: 5.717

9.  Association between biomarkers of bone health and osteosarcopenia among Iranian older people: The Bushehr Elderly Health (BEH) program.

Authors:  Maryam Fathi; Ramin Heshmat; Mehdi Ebrahimi; Ahmad Salimzadeh; Afshin Ostovar; Ali Fathi; Farideh Razi; Iraj Nabipour; Maryam Moghaddassi; Gita Shafiee
Journal:  BMC Geriatr       Date:  2021-11-19       Impact factor: 3.921

10.  Associated Factors of Sarcopenia in Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis.

Authors:  Qianqian Gao; Kaiyan Hu; Chunjuan Yan; Bing Zhao; Fan Mei; Fei Chen; Li Zhao; Yi Shang; Yuxia Ma; Bin Ma
Journal:  Nutrients       Date:  2021-11-27       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.